| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
34,000,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
18,050 |
Avg
Vol: |
18,000 |
| 52
Week Range: |
$238.6 - $238.6 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Quart Barry D |
|
– • – |
2014-06-20 |
4 |
OE |
$25.00 |
$34,375 |
D/D |
1,375 |
1,375 |
|
- |
|
| Baker Bros Advisors Llc |
Director |
– • • |
2014-06-20 |
4 |
OE |
$60.45 |
$1,798,388 |
I/I |
29,750 |
223,864 |
|
- |
|
| Quart Barry D |
|
– • – |
2014-06-17 |
4 |
AS |
$90.00 |
$90,000 |
D/D |
(1,000) |
0 |
|
- |
|
| Quart Barry D |
|
– • – |
2014-06-17 |
4 |
OE |
$23.95 |
$23,950 |
D/D |
1,000 |
1,000 |
|
- |
|
| Quart Barry D |
|
– • – |
2014-06-12 |
4 |
AS |
$83.31 |
$83,310 |
D/D |
(1,000) |
0 |
|
- |
|
| Quart Barry D |
|
– • – |
2014-06-12 |
4 |
OE |
$23.00 |
$23,000 |
D/D |
1,000 |
1,000 |
|
- |
|
| Goldberg Mark Alan |
EVP, Medical & Reg. Strategy |
• – – |
2014-06-11 |
4 |
AS |
$80.00 |
$1,727,760 |
D/D |
(21,597) |
459 |
|
- |
|
| Goldberg Mark Alan |
EVP, Medical & Reg. Strategy |
• – – |
2014-06-11 |
4 |
OE |
$0.95 |
$165,513 |
D/D |
21,597 |
22,056 |
|
- |
|
| Boess Carsten |
SVP, Chief Financial Officer |
• – – |
2014-05-16 |
4 |
AS |
$81.75 |
$813,402 |
D/D |
(9,927) |
0 |
|
- |
|
| Boess Carsten |
SVP, Chief Financial Officer |
• – – |
2014-05-16 |
4 |
OE |
$1.70 |
$16,876 |
D/D |
9,927 |
9,927 |
|
- |
|
| Baker Bros Advisors Llc |
Director |
– • • |
2014-04-23 |
4 |
OE |
$65.10 |
$3,645,600 |
I/I |
56,000 |
219,614 |
|
- |
|
| Quinn Anthony |
EVP, CMO & Head of R&D |
• – – |
2014-04-01 |
4 |
OE |
$0.95 |
$9,500 |
D/D |
10,000 |
25,524 |
|
- |
|
| Quinn Anthony |
EVP, CMO & Head of R&D |
• – – |
2014-04-01 |
4 |
AS |
$82.80 |
$1,670,691 |
D/D |
(20,000) |
15,524 |
|
- |
|
| Quinn Anthony |
EVP, CMO & Head of R&D |
• – – |
2014-04-01 |
4 |
OE |
$0.95 |
$239,500 |
D/D |
20,000 |
35,524 |
|
- |
|
| Heberlig Chris |
Group Vice President, Finance |
• – – |
2014-03-12 |
4 |
AS |
$96.75 |
$755,992 |
D/D |
(7,670) |
192 |
|
- |
|
| Heberlig Chris |
Group Vice President, Finance |
• – – |
2014-03-12 |
4 |
OE |
$0.95 |
$118,924 |
D/D |
7,670 |
7,862 |
|
- |
|
| 14159, L.p. |
Director |
– • • |
2014-03-06 |
4 |
B |
$105.75 |
$39,656,250 |
I/I |
375,000 |
211,614 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2014-03-06 |
4 |
B |
$105.75 |
$39,656,250 |
I/I |
375,000 |
211,614 |
2.25 |
- |
|
| Boess Carsten |
SVP, Chief Financial Officer |
• – – |
2014-02-18 |
4 |
AS |
$100.07 |
$1,012,369 |
D/D |
(9,927) |
0 |
|
- |
|
| Boess Carsten |
SVP, Chief Financial Officer |
• – – |
2014-02-18 |
4 |
OE |
$1.70 |
$16,876 |
D/D |
9,927 |
9,927 |
|
- |
|
| Patel Sanj K |
President & CEO |
• • – |
2014-01-29 |
4 |
AS |
$87.19 |
$4,483,953 |
D/D |
(50,971) |
1,031 |
|
- |
|
| Patel Sanj K |
President & CEO |
• • – |
2014-01-29 |
4 |
OE |
$3.52 |
$179,418 |
D/D |
50,971 |
52,002 |
|
- |
|
| Patel Sanj K |
President & CEO |
• • – |
2014-01-28 |
4 |
AS |
$87.16 |
$4,531,045 |
D/D |
(51,329) |
1,031 |
|
- |
|
| Patel Sanj K |
President & CEO |
• • – |
2014-01-28 |
4 |
OE |
$0.95 |
$127,874 |
D/D |
51,329 |
52,360 |
|
- |
|
| Quinn Anthony |
EVP, CMO & Head of R&D |
• – – |
2013-12-31 |
4 |
A |
$36.30 |
$6,970 |
D/D |
192 |
15,524 |
|
- |
|
372 Records found
|
|
Page 4 of 15 |
|
|
